BioCentury | Apr 11, 2020
Management Tracks

Harpal Kumar named president of Grail Europe; plus Notable, Oncoceutics, ReAlta, Parker Institute

...Labs Inc. Oncoceutics Inc. Parker Institute for Cancer Immunotherapy Bolt Biotherapeutics Inc. BioSpecifics Technologies Corp. CMAB Biopharma (Suzhou) Inc. Exicure Inc. ObsEva S.A. Acacia Pharma...
BioCentury | Apr 10, 2020
Management Tracks

Shakeup at Arix; plus Emergent, AlloVir, Asklepios Bio, Morphic, Gritstone and more

...Inc. Calliditas Therapeutics AB Gadeta B.V. Seres Therapeutics Inc. Dynamk Capital Polyneuron Pharmaceuticals AG Vor Biopharma Inc. Prime Therapeutics LLC Oncoceutics Inc. Exicure Inc. ObsEva S.A. Acacia Pharma...
BioCentury | Mar 4, 2020
Management Tracks

Karp, Ghosh depart Biogen; plus Exelixis, Senti, Applied Therapeutics, Oncopeptides, Acacia and more

...the oncology, HIV, and inflammation business areas at the Sweden unit of Gilead Sciences (NASDAQ:GILD). Acacia Pharma...
...to December 2018. BioCentury Staff Applied Therapeutics Inc. twoXAR Inc. Rafael Pharmaceuticals Inc. Addex Therapeutics Ltd. Celyad S.A. Sumitomo Dainippon Pharma Co. Ltd. Acacia Pharma...
BioCentury | Feb 28, 2020
Product Development

Feb. 27 Quick Takes: FDA approves Biohaven’s migraine therapy, plus Acacia, Zogenix, Ultragenyx-Kyowa, GSK, Illumina-BGI

...in after-hours trading. Acacia wins FDA approval for PONV therapy FDA approved Barhemsys amisulpride from Acacia Pharma...
...Staff Zydis, rimegepant (BHV-3000, bms-927711) Barhemsys, amisulpride (Baremsis, aca1421, apd421) Biohaven Pharmaceutical Holding Co. Ltd. BGI Genomics Co. Ltd. BGI Group Acacia Pharma...
BioCentury | Jan 17, 2020
Company News

Management tracks: Sun departs as Hengrui chair; plus Blackstone, Ipsen, bluebird, BioNTech, Catalent, Foundation, Twist, Lantheus, Abcam and more

...hired Scott Holmes as its first CFO. Holmes was CFO at Kiadis Pharma N.V. (Euronext:KDS). Acacia Pharma...
...Inc. The company is developing diagnostics and CRISPR-based gene therapies for eye diseases. BioCentury Staff Disarm Therapeutics Inc. Acacia Pharma...
BioCentury | Jul 19, 2019
Company News

Management tracks: Iovance, ViiV, Hercules, Pappas and more

...Matthew Boyer will succeed CFO Ford Worthy, who will remain a partner and senior adviser. Acacia Pharma...
...a new position. She was VP and head of clinical development at Zafgen Inc. (NASDAQ:ZFGN). BioCentury Staff Acacia Pharma...
BioCentury | May 3, 2019
Company News

May 3 Company Quick Takes: NHS England, Acacia, Insys, Novo, AZ

...FDA FDA issued a second complete response letter to an NDA for Barhemsys amisulpride from Acacia Pharma...
...factor receptor 2; SGLT2 - Sodium-glucose cotransporter 2 BC Staff, Staff Writer Barhemsys, amisulpride (Baremsis, aca1421, apd421) saxagliptin/dapagliflozin/metformin AbbVie Inc. Acacia Pharma...
BioCentury | Apr 8, 2019
Company News

Management tracks: WuXi AppTec, Kymab, Acceleron

...December. Vink was COO at Cubist Pharmaceuticals Inc. Vink is chairman of Targovax A/S (OSE:TRVX), Acacia Pharma...
BioCentury | Apr 6, 2019
Finance

Big caps under pressure

...acquiring Clementia Pharmaceuticals Inc. (NASDAQ:CMTA); Source: BCIQ: BioCentury Online Intelligence Company Product Indication Event Milestone Acacia Pharma...
BioCentury | Jan 12, 2019
Finance

We all fall down

...protection. Table: 4Q18 setbacks Selected 4Q18 regulatory setbacks. Source: BCIQ; BioCentury Online Intelligence Company Setback Acacia Pharma...
Items per page:
1 - 10 of 63
BioCentury | Apr 11, 2020
Management Tracks

Harpal Kumar named president of Grail Europe; plus Notable, Oncoceutics, ReAlta, Parker Institute

...Labs Inc. Oncoceutics Inc. Parker Institute for Cancer Immunotherapy Bolt Biotherapeutics Inc. BioSpecifics Technologies Corp. CMAB Biopharma (Suzhou) Inc. Exicure Inc. ObsEva S.A. Acacia Pharma...
BioCentury | Apr 10, 2020
Management Tracks

Shakeup at Arix; plus Emergent, AlloVir, Asklepios Bio, Morphic, Gritstone and more

...Inc. Calliditas Therapeutics AB Gadeta B.V. Seres Therapeutics Inc. Dynamk Capital Polyneuron Pharmaceuticals AG Vor Biopharma Inc. Prime Therapeutics LLC Oncoceutics Inc. Exicure Inc. ObsEva S.A. Acacia Pharma...
BioCentury | Mar 4, 2020
Management Tracks

Karp, Ghosh depart Biogen; plus Exelixis, Senti, Applied Therapeutics, Oncopeptides, Acacia and more

...the oncology, HIV, and inflammation business areas at the Sweden unit of Gilead Sciences (NASDAQ:GILD). Acacia Pharma...
...to December 2018. BioCentury Staff Applied Therapeutics Inc. twoXAR Inc. Rafael Pharmaceuticals Inc. Addex Therapeutics Ltd. Celyad S.A. Sumitomo Dainippon Pharma Co. Ltd. Acacia Pharma...
BioCentury | Feb 28, 2020
Product Development

Feb. 27 Quick Takes: FDA approves Biohaven’s migraine therapy, plus Acacia, Zogenix, Ultragenyx-Kyowa, GSK, Illumina-BGI

...in after-hours trading. Acacia wins FDA approval for PONV therapy FDA approved Barhemsys amisulpride from Acacia Pharma...
...Staff Zydis, rimegepant (BHV-3000, bms-927711) Barhemsys, amisulpride (Baremsis, aca1421, apd421) Biohaven Pharmaceutical Holding Co. Ltd. BGI Genomics Co. Ltd. BGI Group Acacia Pharma...
BioCentury | Jan 17, 2020
Company News

Management tracks: Sun departs as Hengrui chair; plus Blackstone, Ipsen, bluebird, BioNTech, Catalent, Foundation, Twist, Lantheus, Abcam and more

...hired Scott Holmes as its first CFO. Holmes was CFO at Kiadis Pharma N.V. (Euronext:KDS). Acacia Pharma...
...Inc. The company is developing diagnostics and CRISPR-based gene therapies for eye diseases. BioCentury Staff Disarm Therapeutics Inc. Acacia Pharma...
BioCentury | Jul 19, 2019
Company News

Management tracks: Iovance, ViiV, Hercules, Pappas and more

...Matthew Boyer will succeed CFO Ford Worthy, who will remain a partner and senior adviser. Acacia Pharma...
...a new position. She was VP and head of clinical development at Zafgen Inc. (NASDAQ:ZFGN). BioCentury Staff Acacia Pharma...
BioCentury | May 3, 2019
Company News

May 3 Company Quick Takes: NHS England, Acacia, Insys, Novo, AZ

...FDA FDA issued a second complete response letter to an NDA for Barhemsys amisulpride from Acacia Pharma...
...factor receptor 2; SGLT2 - Sodium-glucose cotransporter 2 BC Staff, Staff Writer Barhemsys, amisulpride (Baremsis, aca1421, apd421) saxagliptin/dapagliflozin/metformin AbbVie Inc. Acacia Pharma...
BioCentury | Apr 8, 2019
Company News

Management tracks: WuXi AppTec, Kymab, Acceleron

...December. Vink was COO at Cubist Pharmaceuticals Inc. Vink is chairman of Targovax A/S (OSE:TRVX), Acacia Pharma...
BioCentury | Apr 6, 2019
Finance

Big caps under pressure

...acquiring Clementia Pharmaceuticals Inc. (NASDAQ:CMTA); Source: BCIQ: BioCentury Online Intelligence Company Product Indication Event Milestone Acacia Pharma...
BioCentury | Jan 12, 2019
Finance

We all fall down

...protection. Table: 4Q18 setbacks Selected 4Q18 regulatory setbacks. Source: BCIQ; BioCentury Online Intelligence Company Setback Acacia Pharma...
Items per page:
1 - 10 of 63